Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Osteoblasts secrete miRNA-containing extracellular vesicles that enhance expansion of human umbilical cord blood cells.

Morhayim J, van de Peppel J, Braakman E, Rombouts EW, Ter Borg MN, Dudakovic A, Chiba H, van der Eerden BC, Raaijmakers MH, van Wijnen AJ, Cornelissen JJ, van Leeuwen JP.

Sci Rep. 2016 Sep 2;6:32034. doi: 10.1038/srep32034.

2.

Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.

Ballen K, Woo Ahn K, Chen M, Abdel-Azim H, Ahmed I, Aljurf M, Antin J, Bhatt AS, Boeckh M, Chen G, Dandoy C, George B, Laughlin MJ, Lazarus HM, MacMillan ML, Margolis DA, Marks DI, Norkin M, Rosenthal J, Saad A, Savani B, Schouten HC, Storek J, Szabolcs P, Ustun C, Verneris MR, Waller EK, Weisdorf DJ, Williams KM, Wingard JR, Wirk B, Wolfs T, Young JA, Auletta J, Komanduri KV, Lindemans C, Riches ML.

Biol Blood Marrow Transplant. 2016 Sep;22(9):1636-45. doi: 10.1016/j.bbmt.2016.06.012. Epub 2016 Jun 22.

PMID:
27343716
3.

Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.

van Besien K, Hari P, Zhang MJ, Liu HT, Stock W, Godley L, Odenike O, Larson R, Bishop M, Wickrema A, Gergis U, Mayer S, Shore T, Tsai S, Rhodes J, Cushing MM, Korman S, Artz A.

Haematologica. 2016 May;101(5):634-43. doi: 10.3324/haematol.2015.138594. Epub 2016 Feb 11.

4.

Cord Blood as a Source of Natural Killer Cells.

Mehta RS, Shpall EJ, Rezvani K.

Front Med (Lausanne). 2016 Jan 5;2:93. doi: 10.3389/fmed.2015.00093. eCollection 2015. Review.

5.

Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Omer AK, Weisdorf DJ, Lazaryan A, Shanley R, Blazar BR, MacMillan ML, Brunstein C, Bejanyan N, Arora M.

Biol Blood Marrow Transplant. 2016 May;22(5):879-83. doi: 10.1016/j.bbmt.2015.12.020. Epub 2015 Dec 29.

PMID:
26743342
6.

Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials.

Mehta RS, Rezvani K, Olson A, Oran B, Hosing C, Shah N, Parmar S, Armitage S, Shpall EJ.

Front Med (Lausanne). 2015 Dec 11;2:89. doi: 10.3389/fmed.2015.00089. eCollection 2015. Review.

7.

Myeloablative, but not Reduced-Intensity, Conditioning Overcomes the Negative Effect of Flow-Cytometric Evidence of Leukemia in Acute Myeloid Leukemia.

Ustun C, Courville EL, DeFor T, Dolan M, Randall N, Yohe S, Bejanyan N, Warlick E, Brunstein C, Weisdorf DJ, Linden MA.

Biol Blood Marrow Transplant. 2016 Apr;22(4):669-75. doi: 10.1016/j.bbmt.2015.10.024. Epub 2015 Nov 10.

8.

Residues 39-56 of Stem Cell Factor Protein Sequence Are Capable of Stimulating the Expansion of Cord Blood CD34+ Cells.

Shen B, Jiang W, Fan J, Dai W, Ding X, Jiang Y.

PLoS One. 2015 Oct 27;10(10):e0141485. doi: 10.1371/journal.pone.0141485. eCollection 2015.

9.

Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse Model.

Escobedo-Cousin M, Jackson N, Laza-Briviesca R, Ariza-McNaughton L, Luevano M, Derniame S, Querol S, Blundell M, Thrasher A, Soria B, Cooper N, Bonnet D, Madrigal A, Saudemont A.

PLoS One. 2015 Oct 14;10(10):e0138623. doi: 10.1371/journal.pone.0138623. eCollection 2015.

10.

Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation.

de Haar C, Plantinga M, Blokland NJ, van Til NP, Flinsenberg TW, Van Tendeloo VF, Smits EL, Boon L, Spel L, Boes M, Boelens JJ, Nierkens S.

Oncoimmunology. 2015 May 27;4(11):e1023973. eCollection 2015 Nov.

11.

Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation.

Brunstein CG, Petersdorf EW, DeFor TE, Noreen H, Maurer D, MacMillan ML, Ustun C, Verneris MR, Miller JS, Blazar BR, McGlave PB, Weisdorf DJ, Wagner JE.

Biol Blood Marrow Transplant. 2016 Mar;22(3):487-92. doi: 10.1016/j.bbmt.2015.09.025. Epub 2015 Sep 30.

PMID:
26431630
12.

Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34(+) Transplants.

van der Garde M, van Pel M, Millán Rivero JE, de Graaf-Dijkstra A, Slot MC, Kleinveld Y, Watt SM, Roelofs H, Zwaginga JJ.

Stem Cells Dev. 2015 Nov 15;24(22):2649-59. doi: 10.1089/scd.2015.0138. Epub 2015 Oct 8.

PMID:
26414086
13.

Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.

Lazaryan A, Weisdorf DJ, DeFor T, Brunstein CG, MacMillan ML, Bejanyan N, Holtan S, Blazar BR, Wagner JE, Arora M.

Biol Blood Marrow Transplant. 2016 Jan;22(1):134-40. doi: 10.1016/j.bbmt.2015.09.008. Epub 2015 Sep 11.

PMID:
26365153
14.

Engineering the hematopoietic stem cell niche: Frontiers in biomaterial science.

Choi JS, Mahadik BP, Harley BA.

Biotechnol J. 2015 Oct;10(10):1529-45. doi: 10.1002/biot.201400758. Epub 2015 Sep 10. Review.

15.

Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies.

Shah GL, Shune L, Purtill D, Devlin S, Lauer E, Lubin M, Bhatt V, McElrath C, Kernan NA, Scaradavou A, Giralt S, Perales MA, Ponce DM, Young JW, Shah M, Papanicolaou G, Barker JN.

Biol Blood Marrow Transplant. 2015 Dec;21(12):2160-6. doi: 10.1016/j.bbmt.2015.08.010. Epub 2015 Aug 10.

PMID:
26271191
16.

Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.

Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI, Omel JL, Orchard PJ, Palmer J, Saber W, Savani BN, Veys PA, Bredeson CN, Giralt SA, LeMaistre CF; American Society for Blood and Marrow Transplantation.

Biol Blood Marrow Transplant. 2015 Nov;21(11):1863-9. doi: 10.1016/j.bbmt.2015.07.032. Epub 2015 Aug 7.

17.

Better allele-level matching improves transplant-related mortality after double cord blood transplantation.

Oran B, Cao K, Saliba RM, Rezvani K, de Lima M, Ahmed S, Hosing CM, Popat UR, Carmazzi Y, Kebriaei P, Nieto Y, Rondon G, Willis D, Shah N, Parmar S, Olson A, Moore B, Marin D, Mehta R, Fernández-Viña M, Champlin RE, Shpall EJ.

Haematologica. 2015 Oct;100(10):1361-70. doi: 10.3324/haematol.2015.127787. Epub 2015 Aug 6.

18.

Alternative Donor Transplantation for Acute Myeloid Leukemia.

Bejanyan N, Haddad H, Brunstein C.

J Clin Med. 2015 Jun 9;4(6):1240-68. doi: 10.3390/jcm4061240. Review.

19.

High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.

Ponce DM, Hilden P, Devlin SM, Maloy M, Lubin M, Castro-Malaspina H, Dahi P, Hsu K, Jakubowski AA, Kernan NA, Koehne G, O'Reilly RJ, Papadopoulos EB, Perales MA, Sauter C, Scaradavou A, Tamari R, van den Brink MR, Young JW, Giralt S, Barker JN.

Biol Blood Marrow Transplant. 2015 Nov;21(11):1985-93. doi: 10.1016/j.bbmt.2015.07.029. Epub 2015 Jul 31.

PMID:
26238810
20.

The role and potential of umbilical cord blood in an era of new therapies: a review.

Roura S, Pujal JM, Gálvez-Montón C, Bayes-Genis A.

Stem Cell Res Ther. 2015 Jul 2;6:123. doi: 10.1186/s13287-015-0113-2. Review.

Items per page

Supplemental Content

Write to the Help Desk